Normal blood sugar levels in gestational diabetes may not reduce CVD risk

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-02-13 06:15 GMT   |   Update On 2021-02-13 09:57 GMT

USA: Attaining normal blood sugar levels (normoglycemia) does not reduce the risk of midlife cardiovascular disease (CVD) in women with previous gestational diabetes (GD), reveals a recent study in the AHA journal Circulation. In light of the findings, screening women with prior GD for CVD becomes important.Gestational diabetes leads to heightened risk and earlier onset of type 2 diabetes --...

Login or Register to read the full article

USA: Attaining normal blood sugar levels (normoglycemia) does not reduce the risk of midlife cardiovascular disease (CVD) in women with previous gestational diabetes (GD), reveals a recent study in the AHA journal Circulation. In light of the findings, screening women with prior GD for CVD becomes important.

Gestational diabetes leads to heightened risk and earlier onset of type 2 diabetes -- a strong risk factor for CVD. However, it remains unclear if attaining normal levels of blood sugar can improved the excess risk of CVD associated with GD history. The study by Erica P. Gunderson, Division of Research, Kaiser Permanente Northern California, Oakland, CA, and colleagues aimed to evaluate GD history and glucose tolerance after pregnancy associated with coronary artery calcification (CAC) in women -- a predictor of CVD clinical events and manifestation of atherosclerotic CVD.

For the purpose, the researchers extracted data from the CARDIA study (Coronary Artery Risk Development in Young Adults), US multicenter, community-based prospective cohort of young Black (50%) and White adults aged 18 to 30 years at baseline (1985–1986).

The sample included 1133 women without diabetes at baseline having ≥1 singleton births (n=2066) during followup. Glucose tolerance testing at baseline and up to 5 times during 25 years (1986–2011), GD status, and CAC measurements obtained from 1 or more follow up examinations at years 15, 20, and 25 (2001–2011). CAC was measured by noncontrast cardiac computed tomography; dichotomized as Any CAC (score>0) or No CAC (score=0).  

Key findings of the study include:

  • CAC was present in 25% (34/139) of women with GD and 15% (149/994) of women with no GD.
  • In comparison with no GD/normoglycemia, adjusted hazard ratios were 1.54 for no GD/prediabetes and 2.17 for no GD/incident diabetes, and 2.34, 2.13, and 2.02 for GD/ normoglycemia, GD/prediabetes, and GD/incident diabetes, respectively.

"Women without previous GD showed a graded increase in the risk of CAC associated with worsening glucose tolerance. Women with a history of GD had a 2-fold higher risk of CAC across all subsequent levels of glucose tolerance," wrote the authors. 

"Midlife atherosclerotic CVD risk among women with previous GD is not diminished by attaining normoglycemia."

The study titled, "Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife: The CARDIA Study," is published in the AHA journal Circulation.

DOI: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047320

Tags:    
Article Source : Circulation

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News